Tenax Therapeutics (Formerly Known As Oxygen Biotherapeutics, Inc.)

288 articles about Tenax Therapeutics (Formerly Known As Oxygen Biotherapeutics, Inc.)

• Oxygen Biotherapeutics, Inc. Announces License Agreement for Its Glucose Biosensor Technology

  9/22/2008

• Oxygen Biotherapeutics, Inc. to Present at Horizon Finance Group Investor Conferences in Switzerland

  9/15/2008

• Oxygen Biotherapeutics, Inc. Names Robert F. Diegelmann to Lead New Wound Care Division

  9/12/2008

• Oxygen Biotherapeutics, Inc. Sets FDA Meeting Date for Proposed Phase IIb Oxycyte Clinical Trial

  9/10/2008

• Oxygen Biotherapeutics, Inc. to Meet With FDA to Discuss Proposed Phase II-b Oxycyte Clinical Trial

  8/25/2008

• Oxygen Biotherapeutics, Inc. Develops Gel Version of Oxycyte(R) for Treating Surface Wounds

  8/12/2008

• Oxygen Biotherapeutics, Inc. Release: Published Study Shows Oxycyte Successfully Reduces Oxygen Shortages in a Spinal Cord Injury Model

  7/30/2008

• Oxygen Biotherapeutics Provides Update on Recent Events and Phase IIb Oxycyte Clinical Trial

  7/10/2008